APA (7th ed.) Citation

Cui, H., Shu, S., Zhang, N., Wang, M., Yang, T., Wang, Z., . . . Song, J. (2025). Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy. BMC Medicine, 23(1), . https://doi.org/10.1186/s12916-025-04024-y

Chicago Style (17th ed.) Citation

Cui, Hao, et al. "Plasma CCL3 Predicts Adverse Heart Failure Outcomes in Patients with Arrhythmogenic Cardiomyopathy." BMC Medicine 23, no. 1 (2025). https://doi.org/10.1186/s12916-025-04024-y.

MLA (9th ed.) Citation

Cui, Hao, et al. "Plasma CCL3 Predicts Adverse Heart Failure Outcomes in Patients with Arrhythmogenic Cardiomyopathy." BMC Medicine, vol. 23, no. 1, 2025, https://doi.org/10.1186/s12916-025-04024-y.